All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

15

Reset

15 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • HSK31858Phase 33 trials

    Haisco Pharmaceutical Group Co., Ltd. · Non-cystic Fibrosis Bronchiectasis, Asthma Bronchiale, Bronchiectasis

  • VX-121D-IVA, CTP-656Phase 33 trials

    Vertex Pharmaceuticals · Cystic Fibrosis

  • GalvokimigUCB9741Phase 23 trials

    UCB · Chronic Obstructive Pulmonary Disease With Chronic Bronchitis, Atopic Dermatitis, Non-cystic Fibrosis Bronchiectasis

  • ANG003Phase 21 trial

    Anagram Therapeutics, Inc. · Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)

  • ARCT-032Phase 21 trial

    Arcturus Therapeutics, Inc. · Cystic Fibrosis, CFTR Gene Mutation

  • BX004Combination of nebulized bacteriophages targeting Pseudomonas aeruginosaPhase 21 trial

    BiomX Ltd · Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis (CF)

  • CMTX-101Phase 21 trial

    Clarametyx Biosciences, Inc. · Persistent Infection, Cystic Fibrosis

  • CSL787Phase 21 trial

    CSL Behring · Non-cystic Fibrosis Bronchiectasis

  • ETD001Phase 21 trial

    Enterprise Therapeutics Ltd · Cystic Fibrosis

  • NHS7108Phase 21 trial

    Aimmune Nestlé Health Science US R&D, LLC · Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality

  • RCT2100Phase 21 trial

    ReCode Therapeutics · Cystic Fibrosis

  • RESP302Phase 21 trial

    Thirty Respiratory Limited · Non-Cystic Fibrosis Bronchiectasis

  • RESP303Phase 21 trial

    Thirty Respiratory Limited · Non-Cystic Fibrosis Bronchiectasis

  • RSP-1502Phase 21 trial

    Respirion Pharmaceuticals Pty Ltd · Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa

  • SPL84Phase 21 trial

    SpliSense Ltd. · Cystic Fibrosis

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.